Full Event Guide

This year’s agenda has been refined by our expert scientific advisory board to provide you with a detailed end to end inspection of the drug-device development process.

• Analyze the Impact of Extractables and Leachables

• Integrate Quality Control Systems

• Consolidate International Regulatory Approval

Download the full event guide here.

Past Presentations Pack

Including:

• Suzzette Roan, Associate Director Regulatory Affairs CMC, Combination Products & Medical Devices, Biogen
• Diane Doughty, Scientist, Drug Delivery & Devices, MedImmune
• Wendy Shieu, Engineer II, Genentech
• Stephen Barat, Executive Director, Non-Clinical and Translational Sciences Safety Assessment and Bioanalysis, Actavis
• Tiffany McIntire, Human Factors Engineer, Eli Lilly